LIANY
Price:
$0.107
Market Cap:
$11.68M
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor and NX-13 for ulcerative colitis and Cro...[Read more]
Industry
Biotechnology
IPO Date
2021-11-01
Stock Exchange
OTC
Ticker
LIANY
According to LianBio’s latest financial reports and current stock price. The company's current PE Ratio is -0.08. This represents a change of -94.97% compared to the average of -1.59 of the last 4 quarters.
The mean historical PE Ratio of LianBio over the last ten years is -10.50. The current -0.08 PE Ratio has changed -23.83% with respect to the historical average. Over the past ten years (40 quarters), LIANY's PE Ratio was at its highest in in the December 2023 quarter at 0.31. The PE Ratio was at its lowest in in the September 2021 quarter at -28.29.
Average
-10.50
Median
-2.48
Minimum
-60.88
Maximum
11.59
Discovering the peaks and valleys of LianBio PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 647.36%
Maximum Annual PE Ratio = 11.59
Minimum Annual Increase = -196.50%
Minimum Annual PE Ratio = -60.88
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 11.59 | 647.36% |
| 2023 | 1.55 | -196.50% |
| 2022 | -1.61 | -52.21% |
| 2021 | -3.36 | -67.40% |
| 2020 | -10.31 | -83.06% |
The current PE Ratio of LianBio (LIANY) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.84
5-year avg
-0.43
10-year avg
-10.50
LianBio’s PE Ratio is greater than Chimeric Therapeutics Limited (-0.76), greater than Quantum Genomics S.A. (-0.79), greater than Inhibitor Therapeutics, Inc. (-2.52), greater than Oxford BioDynamics Plc (-0.17), less than Theralink Technologies, Inc. (-0.00), greater than PharmaTher Holdings Ltd. (-4.54), greater than Curative Biotechnology, Inc. (-2.45), greater than Univec, Inc. (-4.91), greater than BetterLife Pharma Inc. (-4.74), greater than ProText Mobility, Inc. (-1559.48),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.76 | $7.10M | |
| -0.79 | $6.96M | |
| -2.52 | $8.63M | |
| -0.17 | $8.95M | |
| -0.00 | $615.15K | |
| -4.54 | $7.92M | |
| -2.45 | $8.16M | |
| -4.91 | $6.06M | |
| -4.74 | $7.29M | |
| -1559.48 | $9.34M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like LianBio using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like LianBio or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is LianBio's PE Ratio?
How is the PE Ratio calculated for LianBio (LIANY)?
What is the highest PE Ratio for LianBio (LIANY)?
What is the 3-year average PE Ratio for LianBio (LIANY)?
What is the 5-year average PE Ratio for LianBio (LIANY)?
How does the current PE Ratio for LianBio (LIANY) compare to its historical average?